Stay updated on ARO-APOC3 in Dyslipidemia Clinical Trial

Sign up to get notified when there's something new on the ARO-APOC3 in Dyslipidemia Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the ARO-APOC3 in Dyslipidemia Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The clinical trial study record is no longer displayed; the page instead shows a 403 Forbidden message with a Home link.
    Difference
    16%
    Check dated 2026-10-31T12:49:42.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    A banner announces NIH’s transition to using “Super Intelligence” (SI) in place of “Artificial Intelligence” (AI) across its content.
    Difference
    1%
    Check dated 2026-10-24T12:33:17.000Z thumbnail image
  3. Check
    14 days ago
    Change Detected
    Summary
    The footer’s site revision identifier changed from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-17T13:27:18.000Z thumbnail image
  4. Check
    21 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision changes from v3.7.0 to v3.7.1, while the page continues to show a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-10T13:23:12.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error instead of the study record content, replacing the record details with an error message and navigation, effectively blocking access to the record.
    Difference
    16%
    Check dated 2026-09-19T20:33:22.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    The page shows a software revision from v3.6.5 to v3.6.6, indicating a new build of the site. No study content or public-facing features are changed as per the provided information.
    Difference
    0.0%
    Check dated 2026-08-29T20:17:57.000Z thumbnail image

Stay in the know with updates to ARO-APOC3 in Dyslipidemia Clinical Trial

Enter your email address, and we'll notify you when there's something new on the ARO-APOC3 in Dyslipidemia Clinical Trial page.